Feb 28, 2022
Making a Difference
BCBSMA annual report chronicles extraordinary year of dedication to members, medical partners and community
More than 1 in 3 Blue Cross Blue Shield of Massachusetts members has had a confirmed or suspected case of COVID and the company has spent close to $1 billion on vaccination, treatment and testing for members since the pandemic began, according to the not-for-profit health insurer’s 2021 annual report, published today.
“When life-saving vaccines became available, we mobilized every part of our company to make sure our members and neighbors got access — with clinical expertise, personalized outreach to members, trusted and timely communication, and support for front-line community not-for-profits,” Blue Cross states in the report.
Massachusetts currently ranks No. 1 out of U.S. states for people with at least one vaccination dose administered per capita.
The annual report also details the company’s new partnerships and services, aimed at quality, affordable care with personalized guidance.
And it explores Blue Cross’ deepened commitment to racial and social justice, including a $25 million investment to support health care organizations that are working to ensure equity in health care access and quality.
As a health plan, one of the most powerful tools we have to help guide positive change is the way we pay clinicians who care for our members. This is an evolution of our longstanding work to reward quality care and better outcomes.
- said Blue Cross President and CEO Andrew Dreyfus
Did you find this article informative?
All Coverage content can be reprinted for free.
Read more here.